文献速递重症综合管理与镇静镇痛心脑血管急症

无呼吸试验中预防低氧血症:氧气管吹氧与持续正压通气阀的比较

Prevention of Hypoxemia During Apnea Testing: A Comparison of Oxygen Insufflation And Continuous Positive Airway Pressure.
PubMed 文献 · Neurocrit Care · 2017-01-01
一句话结论两种给氧方式在无呼吸试验中动脉血氧分压与二氧化碳分压变化相似,而每3至5分钟定时采血可缩短试验时间并可能避免pH过度下降。

多中心研究在兩座城市14个ICU连续评估无呼吸试验,采用两种不同方案:一城置入氧气管并按主治医师决定间隔行动脉血气分析,另一城用带持续正压通气阀的复苏球囊连接气管插管并每3至5分钟行动脉血气分析。结果36例用氧气管、50例用持续正压通气阀,两组各1例因生理不稳定中止;动脉血氧分压下降程度(-59 vs -32 mmHg,p=0.72)、二氧化碳分压上升速率(3.2 vs 3.9 mmHg/min,p=0.22)、pH下降速率(-0.02 vs -0.03/min,p=0.06)均无显著差异。定时行动脉血气分析与更短试验时长(10 vs 7 min,p<0.0001)、更小二氧化碳分压升幅(30 vs 26 mmHg,p=0.0007)、更少pH下降(-0.20 vs -0.17,p=0.0012)相关;试验结束时pH更低与血压下降更大相关(p=0.006)。

要点

  • 氧气管与持续正压通气阀两种给氧方式在无呼吸试验中动脉血氧分压、二氧化碳分压变化无显著差异(p=0.72、p=0.22)
  • 36例用氧气管、50例用持续正压通气阀,两组各1例因生理不稳定中止试验
  • 每3至5分钟定时行动脉血气分析者试验时长更短(10 vs 7 min,p<0.0001)
  • 定时行动脉血气分析者二氧化碳分压升幅更小(30 vs 26 mmHg,p=0.0007)、pH下降更少(-0.20 vs -0.17,p=0.0012)
  • 试验结束时pH更低与血压下降更大相关(p=0.006)

适用人群与场景

  • 两座城市14个ICU中连续接受无呼吸试验的患者;两城采用不同给氧方案,一城置入氧气管、按主治医师决定间隔行动脉血气分析,另一城用带持续正压通气阀的复苏球囊连接气管插管并每3至5分钟行动脉血气分析

处置流程与药物剂量

  • 氧气管方案:置入氧气管,动脉血气分析间隔由主治医师决定
  • 持续正压通气阀方案:将带持续正压通气阀的复苏球囊连接气管插管,每3至5分钟行动脉血气分析
  • 两种方案均在试验开始与终止时评估动脉血氧分压、二氧化碳分压、pH和血压

红旗征与不能漏的情况

  • 两组各1例无呼吸试验因生理不稳定而中止

研究设计与关键结果

  • 多中心研究,在兩座城市14个ICU连续评估无呼吸试验,36例用氧气管、50例用持续正压通气阀
  • 动脉血氧分压下降程度:氧气管组-59 mmHg vs 持续正压通气阀组-32 mmHg,p=0.72,无显著差异
  • 二氧化碳分压上升速率:氧气管组3.2 mmHg/min vs 持续正压通气阀组3.9 mmHg/min,p=0.22,无显著差异
  • pH下降速率:氧气管组-0.02/min vs 持续正压通气阀组-0.03/min,p=0.06,无显著差异
  • 定时行动脉血气分析者试验时长更短(10 vs 7 min,p<0.0001)、二氧化碳分压升幅更小(30 vs 26 mmHg,p=0.0007)、pH下降更少(-0.20 vs -0.17,p=0.0012)
  • 试验结束时pH更低与血压下降更大相关(p=0.006)

证据类型、等级与局限

  • 多中心研究,原文未给出证据等级
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者结论认为两种给氧方式在动脉血氧分压与二氧化碳分压变化上相似,定时行动脉血气分析可缩短无呼吸试验时长并可能避免过度pH下降及随之的血流动力学影响

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Apnea testing is an essential step in the clinical diagnosis of brain death. Current international guidelines recommend placement of an oxygen (O2) insufflation catheter into the endotracheal tube to prevent hypoxemia, but use of a continuous positive airway pressure (CPAP) valve may be more effective at limiting arterial partial pressure of O2 (PO2) reduction.

METHODS: We performed a multicenter study assessing consecutive apnea tests in 14 intensive care units (ICUs) in two cities utilizing differing protocols. In one city, O2 catheters are placed and arterial blood gases (ABGs) performed at intervals determined by the attending physician. In the other city, a resuscitation bag with CPAP valve is attached to the endotracheal tube, and ABGs performed every 3-5 min. We assessed arterial PO2, partial pressure of carbon dioxide (PCO2), pH, and blood pressure at the beginning and termination of each apnea test.

RESULTS: Thirty-six apnea tests were performed using an O2 catheter and 50 with a CPAP valve. One test per group was aborted because of physiological instability. There were no significant differences in the degree of PO2 reduction (-59 vs. -32 mmHg, p = 0.72), rate of PCO2 rise (3.2 vs. 3.9 mmHg per min, p = 0.22), or pH decline (-0.02 vs. -0.03 per min, p = 0.06). Performance of ABGs at regular intervals was associated with shorter test duration (10 vs. 7 min, p < 0.0001), smaller PCO2 rise (30 vs. 26 mmHg, p = 0.0007), and less pH reduction (-0.20 vs. -0.17, p = 0.0012). Lower pH at completion of the apnea test was associated with greater blood pressure decline (p = 0.006).

CONCLUSION: Both methods of O2 supplementation are associated with similar changes in arterial PO2 and PCO2. Performance of ABGs at regular intervals shortens apnea test duration and may avoid excessive pH reduction and consequent hemodynamic effects.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Kramer AH, Couillard P, Bader R, et al. Prevention of Hypoxemia During Apnea Testing: A Comparison of Oxygen Insufflation And Continuous Positive Airway Pressure. Neurocrit Care. 2017. PMID: 28176180. doi:10.1007/s12028-017-0380-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。